| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +16% |
| 3Y CAGR | -8% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | -57% |
| 3Y CAGR | +46% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
Neuland LaboratoriesNEULANDLAB | ₹20,204.00 -118.00 (0.58%) | 25,922.60 | 57.28 | 12.78 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,520.30 +17.80 (0.71%) | 19,162.17 | 28.26 | 5.69 | ||
PfizerPFIZER | ₹3,893.30 -24.60 (0.63%) | 17,811.42 | 20.73 | 4.06 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹6,507.00 -7.50 (0.12%) | 16,277.75 | 91.59 | 18.52 |